Multiple Myeloma Resource Center
Welcome to the Multiple Myeloma Resource Center

A collection of recently published journal articles textbooks, images, and review questions focusing on Multiple Myeloma.

Featured Content
New Article: Anticancer Compounds for B-Cell Cancer Therapy

Researchers at The Wistar Institute and collaborators from the University of Notre Dame are developing anticancer compounds targeting a pathway of the endoplasmic reticulum (ER) stress response implicated in the development of multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and lymphoma. The study was published Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research (2020; doi: 10.1158/1535-7163.MCT-20-0127).

Read Article

New Article: New Risk Stratification Model for Smoldering Multiple Myeloma

Researchers at The Wistar Institute and collaborators from the University of Notre Dame are developing anticancer compounds targeting a pathway of the endoplasmic reticulum (ER) stress response implicated in the development of multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and lymphoma. The study was published Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research (2020; doi: 10.1158/1535-7163.MCT-20-0127).

Read Article

Quiz

Originally Published in The Bethesda Review of Clinical Oncology -

In patients with newly diagnosed multiple myeloma receiving initial ther-apy with a combination of bortezomib, lenalidomide, and dexametha-sone, addition of autologous stem cell transplant is associated with

Take the Quiz

New Article: Use of Radiation Before CAR Therapy for Multiple Myeloma

Administering radiation therapy to multiple myeloma patients waiting for CAR T cells to be manufactured was found to be safe and undisruptive to CAR-T therapy, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania who presented the findings at the virtual 2020 ASTRO Annual Meeting (Abstract 35562).

Read Article

Downloadable Chart

The Multiple Myeloma chart provides an overview of cancer of the plasma cells in bone marrow. The chart contains large annotated illustrations, easy-to-read tables and bulleted lists that simplify and condense complex material in an accessible manner.

  • A brief definition of multiple myeloma followed by bulleted lists of risk factors
  • Signs and Symptoms describe common patient complaints
  • Diagnosis/Screening section includes a short succinct list
  • Treatment section includes a list of drug treatments and outlines Stages I, II, and III

Download Now

Case

Originally Published in The Bethesda Review of Clinical Oncology -

A 68- year- old lady is found to have IgA lambda M- spike of 3.1 g/ dL on evaluation for lower back pain. Her hemoglobin is 12 g/ dL, MCV 87 fL, and platelets 212 × 109/ mm3, and serum calcium and creatinine are nor-mal. A skeletal survey reveals no lytic lesions.

Read the Case and take the Quiz